Serum Procalcitonin and Lactoferrin in Detection of Acute Appendicitis; a Diagnostic Accuracy Study by Motie, Mohammad-Reza Motie et al.
Emergency. 2018; 6 (1): e51
ORIGINAL RESEARCH
Serum Procalcitonin and Lactoferrin in Detection of Acute
Appendicitis; a Diagnostic Accuracy Study
Mohammad Reza Motie1, Anvar Soleimani2,3, Arash Soltani2,3, Seyed Isaac Hashemy1,2∗
1. Surgical Oncology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.
2. Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3. Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Received: Apirl 2018; Accepted: August 2018; Published online: 25 August 2018
Abstract: Introduction: Finding an accurate diagnostic test can reduce the rate of unnecessary abdominal surgery in cases
of suspected acute appendicitis (AA). This study aimed to evaluate the diagnostic value of serum lactoferrin (LF)
and procalcitonin (PCT) in detection of patients with acute appendicitis. Methods: In this diagnostic accuracy
study, screening performance characteristics of PCT and LF were calculated in patients suspected with acute
appendicitis and healthy volunteers as control group. Results: 131 cases participated (61 as case and 70 as
control). The mean serum level of LF (0.9±0.14 vs 0.2±0.13 µg/ml; p 0.0001) and PCT (0.15±0.21 vs 0.11±0.02
ng/dl; p = 0.02) were significantly higher in patients suspected with AA. The AUC of PCT and LF were 0.46 (95%
CI: 0.31-0.61) and 0.61 (95%CI: 0.47 - 0.76), respectively. At a 0.90 µg/ml cut-off value, LF had 77% (95 % CI: 63 -
91) sensitivity and 43% (95% CI: 31 - 55) specificity. Also, at a 0.11 ng/dl cut-off value, PCT had 41% (95% CI: 26 -
56) sensitivity and 69% (95% CI: 53 - 85) specificity. Conclusion: Based on the main finding of present study, the
overall accuracy of serum PCT and LF in detection of patients with acute appendicitis are in poor to failed range
and it seems that they could not be considered as good screening tools for this purpose.
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1. Introduction
A
cute appendicitis (AA) is the most common abdomi-
nal emergency worldwide with a significant morbid-
ity and mortality rate. It requires abdominal surgery
with an overall lifetime risk of 8.6% in males and 6.7% in
females (1, 2). The diagnosis of acute appendicitis is chal-
lenging and may be the most common diagnostic problem
in clinical surgery (3). Late diagnosis and delay in surgery of
AA may result in ruptured appendicitis, systemic septic com-
plications and a longer stay at hospital.
Abdominal pain is a common cause for visiting in the emer-
gency department (ED). The initial clinical sign of appen-
dicitis is pain in the lower right quadrant of abdomen or
periumbilical pain, followed by nausea, vomiting and fever.
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This event occurs approximately in 50% of adults (4). How-
ever, the mentioned symptoms are associated with a vari-
ety of pathologies and they do not have sufficient specificity
and sensitivity; therefore, clinical diagnosis of AA from other
pathologies can be challenging and may finally lead to un-
necessary appendectomy. The diagnosis of AA is usually con-
firmed by conventional biomarkers including C-reactive pro-
tein (CRP), white blood cell count (WBC), body temperature
(BT) and absolute neutrophil count (ANC) (5).
Since advances in radiographic imaging, such as ultrasound
and CT scan, have improved the accuracy of diagnosis of AA,
the rate of unnecessary appendectomy has decreased.
However, studies have shown that the prevalence of unnec-
essary appendectomy is around 45%, which is particularly
common in females (1, 4). Therefore, researchers have tried
for decades to find diagnostic markers to increase the accu-
racy and safety of clinical diagnosis of AA.
Several studies have shown that serum level of procalcitonin
(PCT) and lactoferrin (LF) increase during bacterial infec-
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tions (2, 8, 9). PCT, a precursor of calcitonin, is secreted
by C cells of thyroid gland under normal conditions, and
it has been demonstrated to be one of the most important
laboratory markers for the presence of fungal and bacterial
diseases. Unlike other clinical biomarkers such as CRP, the
level of procalcitonin does not change in patients with non-
bacterial and viral infections, which makes it an appropriate
biomarker for AA (10, 11). A lot of studies have assessed the
value of PCT for diagnosing and determining the severity of
acute appendicitis, but the results have been contradictory
and the diagnostic value of procalcitonin in appendicitis is
still unclear (8, 12).
LF is a glycoprotein with a molecular weight of 78 KD. It
has antibacterial properties and acts against a wide range of
gram-positive and gram-negative bacteria. LF is released ex-
actly like other neutrophil proteins following neutrophil ac-
tivity, as seen in individuals with inflammatory bowel dis-
ease, and it quickly appears in the feces (13, 14). Both PCT
and LF are released after neutrophil activation, and their
plasma level can be measured in the serum or plasma (15).
Based on the above-mentioned points, we decided to eval-
uate the diagnostic value of serum LF and PCT in discrimi-
nation of patients with acute appendicitis among suspected
cases.
2. Methods
2.1. Study design and setting
In this diagnostic accuracy study, patients suspected with
acute appendicitis (based on a primary diagnosis by physi-
cians), who had been referred to Imam Reza Hospital, Mash-
had, Iran, from September 2015 to September 2017 were in-
cluded. The study protocol was approved by the Ethics Com-
mittee of Mashhad University of Medical Sciences and writ-
ten informed consent was taken from each patient.
2.2. Participants
Patients more than 16 years old with acute abdominal pain,
who had been referred to emergency department of men-
tioned hospital, were included using convenience sampling
method. In addition, 70 healthy volunteers including males
and females whose sex and age were matched with pa-
tients were enrolled as the control group. Patients with
any evidence of other diseases such as cancer, inflammatory
bowel disease, consumption of steroidal or non-steroidal
anti-inflammatory drugs and antibiotics before their hospi-
talization, patients without any pathological findings, pa-
tients with reactive follicular hyperplasia or chronic appen-
dicitis, and those with certain infectious diseases were ex-
cluded.
2.3. Procedure
Suspected patients were primarily detected at the emergency
triage unit, and then were examined by a surgeon. Alvarado
score (16) was recorded for all patients, and appendectomy
was carried out based on the routine surgery department
protocol. Blood samples for laboratory tests were collected
from all patients on admission before appendectomy. Serum
PCT and LF levels were measured by commercially avail-
able ELISA kits from HyCult Biotechnology (Cat # HK329-01)
for LF and abcam (Cat #ab221828) for PCT. After appendec-
tomy, a histopathology study was conducted on all samples,
and the results were categorized into one of the 5 follow-
ing groups by a pathologist: patients without any patholog-
ical findings (Group 1); patients with reactive follicular hy-
perplasia or chronic appendicitis (Group 2); patients with
acute appendicitis, intact appendix mucosa and a mild to
moderate infiltration of the inflammatory cells (Group 3); pa-
tients with macroscopically or histologically perforated acute
appendicitis, or perforated appendix mucosa accompanied
by a strong pan-mural infiltration of the inflammatory cells
(Group 4); and finally, patients with acute necrotizing ap-
pendicitis (Group 5). The Alvarado scores less than 4 were
defined as unlikely in terms of appendicitis, scores of 5-6
as poor possibility of appendicitis, scores of 7-8 likely and
scores of 9-10 were described as high possibility of appen-
dicitis.
2.4. Reference test
The surgical histopathology finding was used as the confir-
mative test for diagnosis of acute appendicitis.
2.5. Data gathering
Demographic information (age, sex), vital signs (tempera-
ture, heart rate, respiratory rate), white blood cell count
(WBC), neutrophil count, serum level of LF and PCT, pa-
tients’ Alvarado score, as well as the results of surgical
histopathology of appendix were recorded for all participants
using a pre-designed checklist. There were no missing data.
All data were collected prospectively by a trained pathology
resident.
2.6. Statistical Analysis
Due to the small sample size of our study, bootstrap re-
sampling method was carried out to obtain 95% bias-
corrected confidence intervals for each area under the ROC
curve (AUC) (17). An evaluation for the cut-off value of
the biomarkers for the acute appendicitis diagnosis was de-
fined by the Youden index (18). Statistical tests (chi-squared,
Fisher’s exact, logistic regression and independent t-test as
well as Mann Whitey U test (non-parametric independent-
paired comparison)) were used for analyses. Receiver op-
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erator characteristic (ROC) curves were drawn to calculate
the diagnostic accuracy of the studied serum biomarkers (LF,
PCT) with 95% confidence interval (CI). A p value < 0.05 was
considered statistically significant. Statistical analysis was
performed using SPSS11 software, and data were presented
as mean ± standard deviation or frequency (%). The corre-
lation of LF, PCT with pathology and Alvarado scores as well




105 cases were detected as patients suspected to have acute
appendicitis, 80 of which were eligible for inclusion in the
study. 19 (18.1%) patients were pathologically categorized
into non-acute group and 61 patients were confirmed as
acute appendicitis based on surgical histopathology. Base-
line characteristics of studied patients are listed in Table
1. The group suspected with AA and control group were
similar regarding mean age (26.32±10.67 vs 28.97±9.63; p =
0.115) and male to female ratio (34/27 vs 34:36; p = 0.319).
The mean serum level of LF (0.9±0.14 vs 0.2±0.13 µg/ml; p
0.0001) and PCT (0.15±0.21 vs 0.11±0.02 ng/dl; p = 0.02) were
significantly higher in patients suspected with AA.
3.2. Relationships
There was no correlation between serum PCT level and
Alvarado score (r= 0.12, p=0.5), pathology grade (r=0.01,
p=0.31), WBC count (r= 0.06, p=0.57), and neutrophil count
(r= 0.13, p=0.27). In addition, there was no correlation be-
tween serum LF level and Alvarado score (r= 0.21, p=0.12),
pathology grade (r= 0.19, p=0.10), WBC count (r= 0.13,
p=0.23), and neutrophil count (r= 0.17, p=0.15). The corre-
lation coefficient between procalcitonin and lactoferrin was
0.02 (P=0.834).
3.3. Screening performance characteristics of
evaluated parameters
The AUC of PCT and LF were 0.46 (95% CI: 0.31-0.61) and 0.61
(95%CI: 0.47 - 0.76), respectively.
At a 0.90 µg/ml cut-off value, LF had 77% (95% CI: 63 - 91)
sensitivity, 43% (95% CI: 31 - 55) specificity, 0.71 (95% CI:
0.65-0.78) Positive predictive value, 0.29 (CI 95%:0.23-0.35)
negative predictive value, 1.35 (95% CI: 1.12-1.58) positive
likelihood ratio, and 0.53 (95% CI: 0.46-0.60) negative likeli-
hood ratio.
Also, at a 0.11 ng/dl cut-off value, PCT had 41% (95% CI: 26
- 56) sensitivity, 69% (95% CI: 53 - 85) specificity, 0.45 (95%
CI: 0.38-0.52) positive predictive value, 0.04 (CI 95%: 0.02-
0.06) negative predictive value, 1.32 (95% CI: 1.10-1.60) pos-
itive likelihood ratio, and 0.85 (95% CI: 0.55-1.25) negative
Table 1: Baseline Characteristics of patients suspected with acute
appendicitis (AA) (n=80)
Baseline Characteristics Suspected to AA
Age (year)




Mean ± SD 37.22± 0.63
WBC (103 mm3)
Mean ± SD 13.28±4.1
Neutrophil (%)
Mean ± SD 76.05±16
Symptoms n (%)




Mean ± SD 0.9±0.14
Procalcitonin (ng/dl)












Figure 1: Area under the ROC curve of lactoferrin, procalcitonin,
white blood cell count, neutrophil count, and Alvarado score in de-
tection of patients with acute appendicitis.
likelihood ratio. Table 2 and figure 1 show the screening per-
formance characteristics of WBC, neutrophil count, and Al-
varado score for comparison with PCT and LF.
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Table 2: Screening performance characteristics of lactoferrin (µg/ml), procalcitonin (ng/dl), white blood cell (WBC) count (× 103mm3), neu-
trophil count, and Alvarado score in detection of patients with acute appendicitis
Variable Cut-off Sensitivity Specificity AUC
Lactoferrin 0.90 77(63- 91) 43(31-55) 0.61 (0.47 - 0.76)
Procalcitonin 0.11 41(26-56) 69(53-85) 0.46 (0.31-0.61)
WBC count 10 85(72-98) 45(32-58) 0.70 (0.57-0.83)
Neutrophil 75 72( 60-84) 69(52-86) 0.71 (0.58-0.84)
Alvarado 7 95(91-99) 22(16-28) 0.66 (0.50-0.81)
All measures were presented with 95% confidence interval. AUC: area under the ROC curve.
4. Discussion
Diagnosis of patients with appendicitis is a big challenge in
Emergency Department; therefore, a lot of negative appen-
dectomies have been observed. A correct and early diagnosis
of the disease is vital to decrease its morbidity of perforated
cases and also to prevent unnecessary surgery for misdiag-
nosed cases (6). In this regard, a lot of clinical studies have
been carried out in order to identify gold markers to reach a
better diagnosis. The most accurate clinical biomarkers pre-
sented for diagnosis of this disease are CRP and WBC. How-
ever, they do not have the ability to discriminate all true pa-
tients among suspected subjects (8, 19). In our study, we
measured the serum level of lactoferrin and procalcitonin be-
tween suspected acute appendicitis cases and healthy con-
trols. The comparison of these biomarkers showed a signifi-
cant difference between patients with acute appendicitis and
healthy controls.
In consistence with our study, another study on new
biomarkers for acute appendicitis showed a significant
difference of lactoferrin between acute appendicitis and
healthy controls (9). In another study, the plasma level of
procalcitonin in patients with confirmed acute appendicitis
was reported to be more than the control group (0.5 ng/ml
serum level for patients) (20). We evaluated the correlation of
lactoferrin and procalcitonin with eachother and other crite-
ria including WBC, neutrophil count and Alvarado score. We
could not find any correlation between these parameters.
We separated the acute appendicitis cases from non-
appendicitis via pathology score after appendectomy. ROC
curve analysis showed the best accuracy test for diagnosis of
appendicitis is neutrophil count with the AUC of 0.71 and at
a defined cut-off of 75%; sensitivity and specificity were 72%
and 69%, respectively. The accuracy of test for lactoferrin and
procalcitonin were 0.61 and 0.46, respectively.
Since AUC represents the accuracy of the test and AUC of less
than 0.5 is not statistically appropriate for diagnosis of dis-
ease, the serum level of procalcitonin is not a good diagnostic
factor.
However, in one study procalcitonin is introduced as a di-
agnostic marker for acute appendicitis with a sensitivity of
95.65% and a specificity of about 100% (11). Moreover,in an-
other study the PCT value of > 0.5 ng/ml is shown to be use-
ful for diagnosis of appendicitis with 73% sensitivity and 94%
specificity (21).
Khan et al. showed that the serum level of procalcitonin
in children with suspected acute appendicitis is higher than
control group (1.12 ng/ml ± 3.28 versus 0.45 ng/ml ± 1.12),
but it is not statistically significant (p=0.3) (22). The inter-
esting point about procalcitonin is the high specificity in all
studies that suggest it as a diagnostic biomarker along with
other parameters with high sensitivity such as WBC, CRP and
neutrophil count.
The accuracy test for lactoferrin was acceptable (AUC > 0.5)
with 77% sensitivity and 43% specificity in determined cut-
off of 0.9µg/ml. Lactoferrin is more accurate and sensitive
than procalcitonin for diagnosis of acute appendicitis. Sevgi
et al. reported a good accuracy (AUC=0.79) for lactoferrin
between cases with uncomplicated appendicitis and non-
appendicitis (13). Our results showed that lactoferrin is less
accurate than WBC, neutrophil and Alvarado score. In our
study, both WBC and Alvarado score had better accuracy,
specificity and sensitivity as well. Alvarado score with the
cut-off of 7 points has the highest sensitivity (95%) while the
specificity was just 22%. It has been shown that the sensi-
tivity and specificity of the Alvarado score vary, ranging from
60% to 80% in different studies (23-26). Apparently, Alvarado
score has more benefits than biomarkers, because whenever
the patient’s condition alters, this scoring system can be eval-
uated more rapidly, repeatedly and easily. Nevertheless, the
combination of both Alvarado score and biomarkers such as
PCT and LF will be more accurate in diagnosis of patients
with appendicitis in the emergency department.
We could find a significant difference between serum level
of lactoferrin and procalcitonin between our patients and
healthy controls; however, the measured parameters did not
have any correlation with each other. Neutrophil and WBC
count seem to be better diagnostic markers for acute appen-
dicitis compared to lactoferrin and procalcitonin. Procalci-
tonin and lactoferrin might have the potential to be used in a
panel with WBC and CRP in order to decrease the number of
false positive and false negative cases.
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jemerg.com
5 Emergency. 2018; 6 (1): e51
5. Limitation
It should be noted that the result of the present study has
been obtained in light of some limitations. First, we had a
small sample size and it did not allow us to make any gener-
alization. Second, the measurement of those parameters is
expensive and takes a few hours, which may be an important
time period in the emergency department. Third, the cut-off
value presented in our study may not work as well in another
study with a different case mix. Lastly, Procalcitonin may not
increase significantly until 8–12 h. Therefore, for patients ad-
mitted early to the emergency department, serum PCT may
not indicate the clinical severity.
6. Conclusion
Based on the main finding of present study, the overall accu-
racy of serum PCT and LF in detection of patients with acute
appendicitis are in poor to failed range and it seems that they
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